Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia

Recruiting now · Not applicable

Conditions studied: Critical Limb-Threatening Ischemia, Critical Limb Ischemia, Critical Lower Limb Ischemia

In brief

The objective of this prospective, multi-center, clinical investigation is to evaluate the MAGNITUDE BRS System for the planned treatment of narrowed infrapopliteal lesions. Up to 30 subjects will be enrolled at approximately 3 clinical sites in Australia.

Key facts

Study ID

NCT06075940

Run by

R3 Vascular Inc.

People needed

30

Starts

2024-03-04

Expected to finish

2030-12-31

Last updated by the study team

2024-04-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Prince of Wales Hopsital — Randwick, New South Wales, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.